Environmental, Social and Governance (ESG) and Sustainability Report

Overview

The report presents Fosun Pharma's 2025 ESG performance across climate, environmental management, access to healthcare and talent. It reports 935,989 ton CO2e total GHG emissions, 9,728,432 m3 water consumption and 48,813 tonnes of waste, alongside 40,603 employees. It also highlights an MSCI ESG rating of AA, rare-disease and global healthcare-access initiatives, and a workforce that was 51.19% female.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 24 March 2026
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services